Novel role of SF1 in alleviating thyroid-associated ophthalmopathy through the AMPK/mTOR signaling pathway.
暂无分享,去创建一个
X. Deng | Tong Chen | Lina Zhang | Xian-bo Zhang | Q. Pan | Yue Guo | T. Xian | Xiaofan Jia | Li Liu | Fuli Man | Li-Xin Guo | T. Guo | Xiao-xiong Wang | Zhuohui Xu | Xiao-xia Wang
[1] Kai Jin,et al. Does rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis , 2018, BMC Ophthalmology.
[2] Guangyao Wu,et al. Overexpression of miR-185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease , 2017, Molecular medicine reports.
[3] J. Ma,et al. [Progression of the pathogenesis of thyroid associated ophthalmopathy]. , 2017, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.
[4] Y. Gong,et al. Transcription of CYP19A1 is directly regulated by SF-1 in the theca cells of ovary follicles in chicken. , 2017, General and comparative endocrinology.
[5] Terry J. Smith,et al. Teprotumumab for Thyroid‐Associated Ophthalmopathy , 2017, The New England journal of medicine.
[6] M. Suyama,et al. Role of Ad4-binding protein/steroidogenic factor 1 in regulating NADPH production in adrenocortical Y-1 cells. , 2017, Endocrine journal.
[7] Yali Zhang,et al. Icariin Inhibits AMPK-Dependent Autophagy and Adipogenesis in Adipocytes In vitro and in a Model of Graves' Orbitopathy In vivo , 2017, Front. Physiol..
[8] A. Gotz-Więckowska,et al. An update on thyroid-associated ophthalmopathy in children and adolescents , 2016, Journal of pediatric endocrinology & metabolism : JPEM.
[9] Wencan Wu,et al. Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy , 2016, PloS one.
[10] C. Chen,et al. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer – a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation , 2015, Oncotarget.
[11] J. Qin,et al. TMP21 modulates cell growth in papillary thyroid cancer cells by inducing autophagy through activation of the AMPK/mTOR pathway. , 2015, International journal of clinical and experimental pathology.
[12] A. Latronico,et al. DAX1 Overexpression in Pediatric Adrenocortical Tumors: A Synergic Role with SF1 in Tumorigenesis , 2015, Hormone and Metabolic Research.
[13] Terry J. Smith,et al. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease. , 2015, JAMA ophthalmology.
[14] Terry J. Smith. TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy , 2015, Nature Reviews Endocrinology.
[15] M. Saji,et al. A novel dual AMPK activator/mTOR inhibitor inhibits thyroid cancer cell growth. , 2015, The Journal of clinical endocrinology and metabolism.
[16] O. Durrani,et al. Are Ethnicity, Social Grade, and Social Deprivation Associated With Severity of Thyroid-Associated Ophthalmopathy? , 2014, Ophthalmic plastic and reconstructive surgery.
[17] T. Ziegler,et al. Steroidogenic factor 1 promotes aggressive growth of castration-resistant prostate cancer cells by stimulating steroid synthesis and cell proliferation. , 2014, Endocrinology.
[18] D. Schlessinger,et al. FOXL2 transcriptionally represses Sf1 expression by antagonizing WT1 during ovarian development in mice , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] J. Achermann,et al. Steroidogenic Factor-1 and Human Disease , 2012, Seminars in Reproductive Medicine.
[20] R. Medhamurthy,et al. Luteinizing hormone regulates inhibin-α subunit expression through multiple signaling pathways involving steroidogenic factor-1 and beta-catenin in the macaque corpus luteum , 2012, Growth factors.
[21] M. J. Vazquez,et al. Hypothalamic mTOR pathway mediates thyroid hormone‐induced hyperphagia in hyperthyroidism , 2012, The Journal of pathology.
[22] P. White,et al. Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. , 2010, Molecular endocrinology.
[23] S. Jyonouchi,et al. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. , 1999, The Journal of clinical endocrinology and metabolism.